-18%

est. 2Y upside i

HealthcareSeries D+

Behavior change and weight management platform using psychology

Rank

#2990

Sector

Digital Health / Consumer Wellness

Est. Liquidity

~2Y

Data Quality

Data: Medium

Noom has real revenue ($750M) but only 10% growth.

Last updated: March 21, 2026

Bull (25%)+100%

GLP-1 Med scales to $300M+. Total $1B+ rev. IPO at 5-7x ($5-7B).

Base (45%)+30%

$800M rev. Noom Med moderate. IPO at 3-4x ($2.4-3.2B). Flat from $3.7B.

Bear (30%)-40%

GLP-1 commoditizes; churn continues; app declines. Below $3.7B peak.

Est. time to liquidity~2.0 years

Preference Stack Risk

moderate

Funding Intensity

17%

$624M raised on $3.7B; 16.9% intensity.

Dilution Risk

moderate

IPO dilution expected.

Secondary Liquidity

limited

Some pre-IPO secondary.

Other — 1 role

View all 1 open roles at Noom →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Noom's data — designed to show you've done your homework.

  • 1

    “GLP-1 Med revenue trajectory?”

  • 2

    “Consumer churn improvements?”

  • 3

    “IPO timeline?”

Cluster Peers

Expected Upside

Omada Health
+39%
Noom
-18%

Community

Valuation Sentiment

Our model estimates -18% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.